Trade name: Entericolix
Active substance: Clostridium perfringens tip C beta toxoid, E. coli, tulpina P4 (adezina F6), E. coli, tulpina P5 (adezina F18ab), E. coli, tulpina P6 (adezina F4ac), E. coli, tulpina P9 (adezina F18ac), E. coli, tulpina P10 (adezina F5 F41)
Therapeutic group: Organic products
Pharmaceutical form: emulsie injectabilă
Presentation: flacon x 50 ml (25 doze)
Target species: swine
Therapeutic action: Porcine (scroafe și scrofițe) Imunizarea pasivă a purceilor împotriva colibacilozei și enteritei necrotice cauzate de C. perfringens.
Waiting period: 0 zile.
Release mode: Cu prescripţie
Authorization number: 200180
Authorization status: Valida
Date of issue of the authorization: 11-11-2020
Authorization valid until: nelimitata
Manufacturer / Serial Release Company: CZ VACCINES, S.A.U., Spania
Licensee: CZ VACCINES, S.A.U., Spania
Remarks: Autorizat prin DCP.